Guangdong Taienkang Pharmaceutical Co., Ltd. Share Price
Equities
301263
CNE1000058X0
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.04 CNY | -0.64% | -1.75% | -14.02% |
Sales 2024 * | 1.17B 161M 12.62B | Sales 2025 * | 1.5B 208M 16.26B | Capitalization | 5.95B 821M 64.25B |
---|---|---|---|---|---|
Net income 2024 * | 315M 43.48M 3.4B | Net income 2025 * | 422M 58.25M 4.56B | EV / Sales 2024 * | 5.09 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.95 x |
P/E ratio 2024 * |
19
x | P/E ratio 2025 * |
14.2
x | Employees | 931 |
Yield 2024 * |
4.99% | Yield 2025 * |
4.99% | Free-Float | 44.62% |
1 day | -0.64% | ||
1 week | -1.75% | ||
Current month | -1.68% | ||
1 month | +0.29% | ||
3 months | -1.68% | ||
6 months | -23.53% | ||
Current year | -14.02% |
Managers | Title | Age | Since |
---|---|---|---|
Han Jie Zheng
CEO | Chief Executive Officer | 61 | 31/12/98 |
Gui Xi Zhou
DFI | Director of Finance/CFO | 37 | 01/12/22 |
Ting Li
BRD | Director/Board Member | 41 | 30/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ying Liang
BRD | Director/Board Member | 52 | 29/06/22 |
Yi Ping Rui
BRD | Director/Board Member | 70 | 02/02/18 |
Han Jie Zheng
CEO | Chief Executive Officer | 61 | 31/12/98 |
Date | Price | Change | Volume |
---|---|---|---|
27/05/24 | 14.04 | -0.64% | 2,003,520 |
24/05/24 | 14.13 | +0.07% | 1,651,940 |
23/05/24 | 14.12 | -4.47% | 2,898,740 |
22/05/24 | 14.78 | +1.16% | 2,275,120 |
21/05/24 | 14.61 | -0.14% | 2,334,580 |
End-of-day quote Shenzhen S.E., May 26, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.02% | 826M | |
+38.51% | 727B | |
+31.74% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 301263 Stock